Product image of Tektrotyd (Hynic-[d-Phe1,tyr3-Octreotide]*tfa) supplied by GNH India

Tektrotyd

Active Ingredient:
Hynic-[d-Phe1,tyr3-Octreotide]*tfa
Origin:
EU

Tektrotyd (Hynic-[d-Phe1,tyr3-Octreotide]*tfa)

Tektrotyd is a radiopharmaceutical used in nuclear medicine imaging. This Hynic-[d-Phe1,tyr3-Octreotide]*tfa compound supports diagnostic procedures. Suitable for intravenous administration in clinical settings. Commonly used for somatostatin receptor imaging.

Manufacturer / TM Owner

Narodowe Centrum Badań Jądrowych

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Tektrotyd is primarily used in diagnostic imaging to visualize somatostatin receptor-positive tumors. It is indicated for patients undergoing nuclear medicine scans to detect neuroendocrine tumors. The compound binds to somatostatin receptors, aiding in the identification of abnormal tissue. It is not a treatment but supports accurate diagnosis.

Side Effects

  • As a diagnostic agent, Tektrotyd produces visible signals on imaging scans, helping clinicians locate targeted tissues. The effects are observed indirectly through imaging equipment rather than direct physiological changes. Patients may experience minimal discomfort during administration, typically related to the injection process.

Precautions & Warnings

  • Tektrotyd should be handled by trained medical professionals in controlled environments. It is administered intravenously, requiring sterile techniques to prevent contamination. Patients with known allergies to octreotide or related compounds should inform their healthcare provider. Pregnant or breastfeeding individuals should discuss risks with their doctor before use.

Avoid Interactions

  • Tektrotyd may interact with other somatostatin analogs or medications affecting somatostatin receptors. Concomitant use of drugs that alter receptor binding should be evaluated by a healthcare provider. Alcohol and certain dietary supplements may influence imaging results; consult a physician for guidance. No major drug-drug interactions are widely reported, but individual cases vary.

Frequently Asked Questions

Tektrotyd is used in nuclear medicine imaging to detect somatostatin receptor-positive tumors.

Tektrotyd is given as an intravenous injection in a clinical setting.

Side effects are typically minimal and related to the injection process, such as mild discomfort.

Pregnant individuals should consult their doctor to assess potential risks before use.

No, Tektrotyd is a diagnostic agent used to aid in imaging, not a cancer treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hynic-[d-Phe1,tyr3-Octreotide]*tfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT